Pathogenesis of rheumatoid arthritis;Pathogenese der rheumatoiden arthritis

Medizinische Klinik

Volumn 92, Issue 6, 1997, Pages 347-353

  Geiler, Thomas ^c   Lorenz, Hanns Martin ^c   Kalden, Joachim R ^c   Manger, Bernhard ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNITY; FIBROBLAST; HUMAN; HYPOTHESIS; INFLAMMATION; PATHOGENESIS; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0030741141     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044776     Document Type: Article

References (85)

1. Arnalich, F., E. de Miguel, M. Martinez, J. J. Vazquez, J. Gijon-Banos, A. Hemanz: Neuropeptides and interleukin-6 in human joint inflammation: relationship between intraarticular substance P and interleukin-6 concentrations. Neurosci. Lett. 170 (1994), 251-254.
2. Bijlsma, J. W. J., R. W. H. M Derksen, O. Huber-Bruning, J. C. C. Borleffs Does AIDS "cure" rheumatoid arthritis? Ann. rheum. Dis. 47 (1988), 350-351.
3. Brinckerhoff, C. E., E. D. Harris Jr.: Survival of rheumatoid synovium implanted into nude mice. Amer. J. Path. 103 (1981), 411-419.
4. Burmester, G. R., D. T. Y. Yu, A.-M. Irani, H. G. Kunkel, R. J. Winchester: Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthr. and Rheum. 24 (1981), 1370-1376.
5. Butler, D. M., R. N. Maini, M. Feldmann, F. M. Brennan: Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor. Europ. Cytokine Netw. 6 (1995), 225-230.
6. Buttice, G., S. Quinones, M. Kurkinen: The AP-1 site is required for basal expression but is not necessary for TPA-response for the stromelysin gene. Nucl. Acids Res. 19 (1991), 3723-3731.
7. Cavender, D. E., D, Galler, G. Olini, R. W. Knowles: Induction of tolerance in non-human primates with OKT-cdr4a, a humanized anti-CD4 monoclonal antibody. 9th Int. Congr. Immunology 1995, p. 609.
8. Choy, E. H. S., I. C. Chikanza, G. H. Kingsley, V. Corrigall, G. S. Panayi: Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti CD4 monoclonal antibody. Scand. J. Immunol. 36 (1992), 291-298.
9. Chu, C. Q., M. Field, M Feldmann, R. N. Maini: Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthr. and Rheum. 34 (1991), 1125-1132.
10. Cush, J. J., P. E. Lipsky: Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthr. and Rheum. 31 (1988), 1230-1238.
11. Deleuran, B. W., C. Q. Chu, M. Field, F. M. Brennan, P. Katsikis, M. Feldmann, R. N. Maini: Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Brit. J. Rheum. 31 (1992), 801-809.
12. Denhardt, D. T., A. H. Greenberg, S. E. Egan, R. T. Hamilton, J. A. Wright: Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene 2 (1987), 55-59.
13. Duby, A. D., A. K. Sinclair, S. L. Osborne-Lawrence, W. Zeldes, L. Kan, D. A. Fox: Clonal heterogeneity of synovial fluid T lymphocytes from patients with rheumatoid arthritis. Proc.nat. Acad. Sci (Wash.) 86 (1989), 6206-6210.
14. Duchosal, M. A.: SCID mice in the study of human autoimmune diseases. Seinin. Immunopath. 14 (1992), 159-177.
15. Elkon, K. B., D. Ashany: The SCID mouse as a vehicle to study autoimmunity. Brit. J. Rheum. 32 (1993), 4-12.
16. Elliott, M. J., R. N. Maini, M. Feldmann, J. R. Kalden, C. Antoni, J. S. Smolen, B. Leeb, F. C. Breedveldt, J. D. Macfarlane, H. Bijl, J N Woody: Randomised doubleblind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344 (1994), 1105-1110.
17. Fassbender, H. G.: Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll. rel. Res. 3(1983), 141-155.
18. Firestein, G. S., J. M Alvaro-Gracia, R. Maki: Quantitative analysis of cytokine gene expression in rheumatoid arthritis [published erratum appeared in J. Immunol. 145 (1990), 1037]. J. Immunol. 144 (1990), 3347-3353
19. Firestein, G. S., N. J. Zvaifler: Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II: Low levels of synovial fluid and synovial tissue interferon suggests that gamma-interferon is not the primary macrophage activating factor. Arthr and Rheum. 30 (1987), 864-871.
20. Fullmer, M. A., J.-Y. Shen, R. L. Modlin,T. H. Rea: Immunohistological evidence of lymphokine production and lymphocyte activation antigens in tuberculin reactions. Clin. exp Immunol. 67 (1987), 383-390.
21. Gay, S., R. E. Gay: Cellular basis and oncogene expression of rheumatoid joint destruction. Rheum. int. 9 (1989), 105-113.
22. Gay, S., A. Tanaka, A. Tarkowski, R. E. Gay, H. G. Fassbender: Expression of oncogenes ras and myc in proliferating synovial lining cells in rheumatoid arthritis. Arthr. and Rheum. 31 (1988), R40.
23. Geiler, T., J. Kriegsmann, G. Keyszer, R, E. Gay, S. Gay: A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthr. and Rheum. 37 (1994), 1664-1671.
24. Goronzy, J. J., P. Bartz-Bazzanella, W. Hu, M. C. Jendro, D. R. Walser-Kuntz, C. M. Weyand: Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J. clin. Invest. 94 (1994), 2068-2076.
25. Gregersen, P. K., J. Silver, J. R. Winchester: The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthr. and Rheum. 30 (1987), 1205-1213.
26. Henderson, B., P. A. Revell, J C. W. Edwards: Synovial lining hyperplasia in rheumatoid arthritis: dogma and fact. Ann. rheum. Dis. 47 (1988), 348-349.
27. Hendrickson, E. A.: The SCID mouse: relevance as an animal model system for studying human disease. Amer. J. Path. 143 (1993), 1511-1522.
28. Homeff, G., G. R. Burmester, F. Emmrich, J. R. Kalden. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthr. and Rheum. 34 (1991), 129-140.
29. Jorgensen, C., J. Sany. Modulation of the immune response by the neuro-endocrine axis an rheumatoid arthritis. Clin exp. Rheum. 12 (1994), 435-441.
30. Keystone, E. C., M Minden, R, Klock, L. Poplonski, J. Zalcberg, T Takadera, T. W. Mak: Structure of T cell antigen receptor beta chain in synovial fluid cells from patients with rheumatoid arthritis. Arthr. and Rheum. 31 (1988), 1555-1557
31. Keyszer, G. M., A. H. Heer, J. Kriegsmaan, T. Geiler, A. Trabandt, M. Keysser, R. E. Gay, S. Gay: Comparative analysis of cathepsin L-, cathepsin D- and collagenasemRNA expression in synovial tissue of patients with rheumatoid arthritis and osteoarthritis by in situ hybridization. Arthr and Rheum. 38 (1995), 976-984.
32. Kinne, R. W., S Boehm, T. Iftner, T. Aigner, S. Vornehm, G. Weseloh, R. Bravo, F. Emmrich, R. A. Kroczek: Synovial fibroblast-like cells strongly express jun-B and c-fos proto-oncogenes in rheumatoid- and osteoarthritis. Scand. J. Rheum., Suppl 101 (1995), 121-125.
33. Kirkham, B. W., C. Pitzalis, G. H. Kingsley, T. C. Chikanza, S. Sabharwal, C. Barbatis, R. Grahame, T. Gibson, P. L. Amlot, G. S. Panayi: Monoclonal antibody therapy in rheumatoid arthritis: the clinical and immunological effects of a CD7 monoclonal antibody. Brit. J. Rheum. 30 (1991), 459-463.
34. Kirkham, B. W., F. Thien, B. K. Pelton, C. Pitzalis, P. Amlot, A. M. Denman, G. S. Panayi: Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis. J. Rheum. 19 (1992), 1348-1352.
35. Klareskog, L., U. Forsum, V. Malmnäs, U. K Tjernlund, D. Kabelitz, A. Wingren: Appearance of anti-HLA-DR-reactive cells in normal and rheumatoid synovial tissue. Scand. J. Immunol. 14 (1981), 183-192.
36. Kobayashi, I., M. Ziff: Electron microscopic studies of the cartilage-pannus junction in rheumatoid arthritis. Arthr. and Rheum.18 (1975), 475-483.
37. Krane, S. M., W. Conca, M. L. Stephenson, E. P. Amento, M. B. Goldring: Mechanisms of matrix degradation in rheumatoid arthritis Ann. N. Y. Acad. Sci. 580 (1990), 340-354.
38. Kremer, J. M., G. F. Petrillo, W. F. C. Rigby, S. J. Plehn, T. G. Woodworth, K. C. Parker, G. S. Taintor: Phase I/II open-label trial of DAB389IL-2 administered to patients with active rheumatoid arthritis receiving treatment with methotrexate. Arthr. and Rheum. 37 (1994), S341.
39. Kriegsmann, J., G. M. Keyszer, T. Geiler, R. Bräuer, R E. Gay, S. Gay: Expression of vascular cell adhesion molecule-1 (VCAM-1) in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab. Invest. 72 (1995), 209-214.
40. Kuroki, Y., S. Shiozawa, R. Yoshihara, H. Hotta: The contribution of human c-fos DNA to cultured synovial cells: a transfection study. J. Rheum. 20 (1993), 422-428.
41. Lafyatis, R., E. F. Remmers, A. B. Roberts, D. E. Yocum, M. B Sporn, R. L. Wilder: Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J. clin. Invest. 83 (1989), 1267-1276.
42. Lea Sewell, K., K. C. Parker, T. G. Woodworth, J. Reuben, W Swartz, D. E. Trentham: DAB486IL-2 fusion toxin in refractory rheumatoid arthritis. Artht. and Rheum. 36 (1993), 1223-1233.
43. Lemaire, R., R. M. Flipo, D. Monte, T. Dupressoir, B. Duquesnoy, J. Y. Cesbron, A. Janin, A. Capron, R. Lafyatis: Synovial fibroblast-like cell transfection with the SV40 large T antigen induces a transformed phenotype and permits transient tumor formation in immunodeficient mice. J. Rheum. 21 (1994), 1409-1419.
44. Levy, R., M. Weisman, C. Wiesenhutter, D. Yocum, T. Schnitzer, A. Goldman, M. Schiff, F. Breedveld, A. Solinger, B. MacDonald, J Lipani: Results of a placebo-controlled, multicenter trial using a primatized non-depleting anti-CD4 monoclonal antibody in the treatment of rheumatoid arthritis. Arthr. and Rheum. 39 (1996), S122.
45. Marlor, C. W., D. L. Webb, M. P. Bombara, J. M. Greve, M. L. Blue: Expression of vascular cell adhesion molecule-1 in fibroblast-like synoviocytes after stimulation with tumor necrosis factor. Amer. J. Path. 140 (1992), 1055-1060.
46. Miller, J. F., R. A. Flavell: T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. Curr. Opin. Immunol. 6 (1994), 892-899.
47. Miossec, P., M. Naviliat, A. Dupuy D'Angeac, J Sany, J. Banchereau: Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid arthritis. Arthr. and Rheum. 33 (1990), 2514-2519.
48. Morales-Ducret, J., E. Wayner, M. J. Elices, J M. AlvaroGracia, N. J. Zvaifler, G. S. Firestein: Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J. Immunol. 149 (1992), 1424-1431.
49. Moreland, L. W., P. W. Pratt, R. P. Bucy, B. S Jackson, J. W. Feldman, W. J. Koopman: Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Arthr. and Rheum. 37 (1994), 834-838.
50. Müller-Ladner, U., J. Kriegsmann, B. Franklin, S. Matsumoto, T. Geiler, R. E. Gay, S. Gay: Synovial fibroblasta of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Amer. J. Path 149 (1996), 1607-1615.
51. Müller-Ladner, U., J. Kriegsmann, R. E. Gay, W. J, Koopman, S. Gay, W W. Chatharn: Progressive joint destruction in a human immunodeficiency virus-infected patient with rheumatoid arthritis. Arthr. and Rheum. 38 (1995), 1328-1332.
52. Ornstein, M. H., L. D. Kerr, H. Spiera: A reexamination of the relationship between active rheumatoid arthritis and the acquired immunodeficiency syndrome. Arthr. and Rheum. 38 (1995), 1701-1706.
53. O'Sullivan, F. X., H. G. Fassbender, S. Gay, W. J. Koopman: Etiopathogenesis of the rheumatoid arthritis-like disease in MRL/1 mice. I. The histomorphologic basis of joint destruction. Arthr. and Rheum. 28 (1985), 529-536.
54. Panayi, G. S., E. H. S. Choy, D J. A. Connolly, T. Regan, V. K. Manna, N. Rapson, G. H. Kingsley, J. M. Johnston: T cell hypothesis in rheumatoid arthritis tested by a humanized non-depleting anti-CD4 monoclonal antibody. Treatment 1: suppression of disease activity and acute phase response. Arthr. and Rheum. 39 (1996), S224.
55. Pasero, G., F. Priolo, E. Marubini, F. Fantini, G. Ferraccioli, M. Magaro, R. Marcolongo, P. Oriente, V. Pipitone, I. Portioli, G. Tirri, F. Trotta, O. Della Casa Alberighi: Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthr. and Rheum. 39 (1996), 1006-1015.
56. Ponteziere, C., D. Desmoulins, J. Agneray, O. G. Ekindjian, M. J. Cals: Comparative proliferation of non-rheumatoid and rheumatoid human synovial cells. Int. J. Tiss. React. 12 (1990), 229-236.
57. Prashar, Y., A. Khanna, P. Sehajpal, V. K. Sharma, M. Suthanthiran: Stimulation of transforming growth fectorbeta transcription by cyclosporine. FEBS-Letters 358 (1995), 109-112.
58. Qu, Z., C. H. Garcia, L, O'Rourke, S R. Planck, M. Kohli, J. T. Rosenbaum: Local proliferation of fibroblastlike synoviocytes contributes to synovial hyperplasia. Arthr. and Rheum. 37 (1994), 212-220.
59. Reiter, C., B. Kakavand, E. P. Rieber, M. Schattenkirchner, G. Riethmüller, K. Krüger: Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Arthr. and Rheum. 34 (1991), 525-536.
60. Rendt, K. E., T. S. Barry, D, M Jones, C. B, Richter, S. S. McCachren, B. F. Haynes: Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes. J. Immunol. 151 (1994), 7324-7336.
61. Rönnelid, J., J. Lysholm, A. Engstrom-Laurent, L. Klareskog, B. Heyman: Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid Evidence for an HLA DR4-restricted IgG response. Arthr. and Rheum. 37 (1994), 1023-1029.
62. Ruderman, E. M., M. E. Weinblatt, L. M. Thurmond, G. S. Pinkus, E. M. Gravallese: Synovial tissue response to treatment with CAMPATH-1H. Arthr. and Rheum. 37 (1994), S420.
63. Sack, U., H. Kuhn, J. Ermann, R. W. Kinne, S. Vogt, D. Jungmichel, F. Emmrich: Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice. J. Rheum. 21 (1994), 10-16.
64. Saxne, T., M. A. Palladino, D. Heinegard, N. Talal, F. A. Wollheim: Detection of tumor necrosis factor α, but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum Arthr. and Rheum. 31 (1988), 1041-1048.
65. Shiozawa, S., K. Shiozawa, T. Fujita: Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus, Arthr. and Rheum. 26 (1983), 472-478.
66. Solovyeva, N. I., T. O. Balayevskaya, E. A. Dilakyan, T. A, Zakamaldina Zama, V. F. Pozdnev, L. Z. Topol, F. L. Kisseljov: Proteolytic enzymes at various stages of oncogenic transformation of rat fibroblasts. I. Aspartyl and cysteine proteinases. Int. J. Cancer 60 (1995), 495-500.
67. Stamenkovic, I., M Stegagno, K. A. Wright, S. M, Krane, E. P. Amento, R. B. Colvin, R. J. Duquesnoy, J, T. Kurnick: Clonal dominance among T lymphocyte infiltrates in arthritis Proc. nat. Acad. Sci. (Wash.) 85 (1988), 1179-1183.
68. Starkebaum, G., N. M. Shasteen, R M. Fleming-Jones, T. P, Loughran, M. Mannik: Sera of patients with rheumatoid arthritis contain antibodies to recombinant human T-lymphotrophic virus type I/II envelope glycoprotein p21. Clin Immunol. Immunpath. 79 (1996), 182-188.
69. Strand, V., P E. Lipsky, G. W Cannon, L. H. Calabrese, C Wiesenhutter, S B. Cohen, N J. Olsen, M L Lee, T. J. Lorenz, B. Nelson: Effects of administration of an antiCD5 plus immunoconjugate in rheumatoid arthritis. Arthr. and Rheum. 36 (1993), 620-630.
70. Stransky, G., J. Vernon, W. K. Aicher, L. W. Moreland, R. E. Gay, S. Gay: Virus-like particles in synovial fluids from patients with rheumatoid arthritis. Brit. J. Rheum. 32 (1993), 1044-1048.
71. Tanaka, A., F. X. O'Sullivan, W. J. Koopman, S. Gay: Etiopathogenesis of rheumatoid arthritis-like disease in MRL/1 mice. II. Ultrastructural basis of joint destruction. J. Rheum. 15 (1988), 10-16.
72. Trabandt, A., W. K. Aicher, R. E. Gay, V. P. Sukhatme, H. G. Fassbender, S. Gay: Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheum. int. 12 (1992), 53-59.
73. Trabandt, A., W. K. Aicher, R. E. Gay, V. P. Sukhatine, M. Nilson-Hamilton, R. T. Hamilton, J. R. McGhee, H. G. Fassbender, S. Gay: Expression of the collagenolytic and Ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/1 mice and patients with rheumatoid arthritis. Matrix 10 (1990), 349-361.
74. Trabandt, A., R. E. Gay, S. Gay: Oncogene activation in rheumatoid synovium. Acta path. microbiol. immunol. scand. (C) 100 (1992), 861-875.
75. Ulfgren, A. K., S. Lindblad, L. Klareskog, J. Andersson, U. Andersson: Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann. rheum. Dis. 54 (1995), 654-661.
76. Van der Lubbe, P. A., A. C. Dijkmans, H, M. Markusse, U. Nässander, F. C. Breedveld: Lack of clinical effect of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthr. and Rheum 37 (1994), S294.
77. Van der Lubbe, P. A., C. Reiter, F. C. Breedveld, K. Krüger, M. Schattenkirchner, M. E. Sanders, G. Riethmüller: Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. Arthr. and Rheum. 36 (1993), 1375-1379.
78. Wahl, S. M., J. B. Allen, H. L. Wong, S. F. Dougherty, L. R. Ellingworth. Antagonistic and agonistic effects of transforming growth factor beta and IL-1 in rheumatoid synovium. J. Immunol. 145 (1990), 2514-2519.
79. Weinblatt, M. E., J. Coblyn, A. Maier, R. Anderson, S. Helfgott, L. Thurmond, W. Spreen, J. Johnston: Continued lymphocyte suppression following single dose mAb therapy with CAMPATH-1H: a 20-month follow up. Arthr. and Rheum 37 (1994), S420.
80. Weyand, C. M., J. J. Goronzy: Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J. clin Invest. 95 (1995), 2120-2126.
81. Weyand, C. M., J. J. Goroazy: Inherited and noninherited risk factors in rheumatoid arthritis. Curr. Opin. Rheum. 7 (1995), 206-213.
82. Wilkinson, L. S., J. C. Edwards, R. N. Poston, D. O. Haskard: Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium. Lab. Invest. 68 (1993), 82-88.
83. Williams, R. O., L. J. Mason, M. Feldmann, R. N. Maini: Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc. rat. Acad. Sci. (Wash.) 91 (1994), 2762-2766.
84. Wordsworth, B. P., J. S. S. Lanchbury, L. I. Sakkas, K. I. Welsh, G. S. Panayi, J. I. Bell: HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc. nat. Acad. Sci. (Wash.) 86 (1989), 10049-10053.
85. Yan, T., H. Burkhardt, T Ritter, B. Broker, K. H. Mann, W. M. Bertling, K. von der Mark, F. Emmrich: Specificity and T cell receptor beta chain usage of a human collagen type II-reactive T cell clone derived from a healthy individual. Europ. J. Immunol. 22 (1992), 51-56.